Breaking News

Financial Report: PAREXEL

January 30, 2013

Revenues up 25% in the quarter


2Q Revenues: $483.1 million (+25%)

2Q Earnings: $21.3 million (+65%)

YTD Revenues: $945.7 million (+26%)

YTD Earnings: $36.4 million (+62%)

Comments: Clinical Research Services (CRS) revenue was $320.6 million in the quarter, up 29%. PAREXEL Consulting & Medical Communications Services (PCMS) revenues were $49.3 million, up 28%. Perceptive Informatics (PI) revenues were $101.4 million, up 12%. Newly-acquired Liquent, Inc. contributed $0.4 million to revenue in the quarter. Backlog at the end of December 2012 was approximately $4.5 billion, up 21%.
blog comments powered by Disqus
  • Quality Risk Management

    Quality Risk Management

    Cheryl Abernathy and Bryan Sasbon, Quality Assurance Operations Manager, Ropack Pharma Solutions; QA Director & Regulatory Affairs, Ropack Pharma Solutions||September 8, 2016
    Embracing the process as a means to a strong quality culture

  • Staying Ahead in the Small Molecule Space

    Staying Ahead in the Small Molecule Space

    Dr. Matthew Moorcroft, VP Global Marketing, Cambrex||September 8, 2016
    Understand what is happening in the market and react accordingly

  • FDA & Drug Development

    FDA & Drug Development

    Rachelle Du2019Souza, Regulatory Heights Inc.||September 8, 2016
    You must perform the necessary due diligence to stay on top of regulatory developments